Reported Nov 10, 2021 · Terminated
Irbesartan Tablets USP, 75 mg a) 30 count (NDC 68180-410-06) and b) 90 count (NDC 68180-410-09) bottles, Rx only
Lupin Pharmaceuticals Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Lupin Pharmaceuticals Inc. · Harborplace Tower · Baltimore, MD · 21202-6174
Is this the product you have?
- Irbesartan Tablets USP, 75 mg a) 30 count (NDC 68180-410-06) and b) 90 count (NDC 68180-410-09) bottles, Rx only
- Lot codes and dates
a) Lot# H000843exp. date 28/02/2023 H805727exp. date 30/11/2021 H901579exp. date 31/03/2022 b) Lot# H000844exp. date 28/02/2023 H000964exp. date 31/03/2023 H804311exp. date 31/08/2021 H805267exp. date 30/11/2021 H805268exp. date 30/11/2021 H805269exp. date 30/11/2021 H805725exp. date 30/11/2021 H805726exp. date 30/11/2021 H901497exp. date 31/01/2022 H901577exp. date 31/03/2022 H901578exp. date 31/03/2022 H902258exp. date 31/05/2022
- Amount recalled
- 51,144 bottles
This recall covers 5 products
The agency filed one notice per product. You are reading one of them; the other 4 are below.
Where it was sold
- Nationwide
Why it was recalled
CGMP Deviations: impurity N-nitrosoirbesartan detected in API
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Lupin Pharmaceuticals Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.